Status:
COMPLETED
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Ovarian Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study will analyze tumor tissue from patients with known genetic mutations (BRCA1, BRCA2, CHK2, etc) who have tumor tissue available from two surgeries, either primary/recurrent, or two different...
Detailed Description
This study will recruit individuals with known BRCA1 and BRCA2 mutations or mutations in similar cancer causing genes such as CHK2 or PALB2 who have had a cancer removed by surgery or biopsied two or ...
Eligibility Criteria
Inclusion
- Male or female
- Age 18 or older
- documented mutation in BRCA1, BRCA2 or other known cancer causing gene
- one or more cancer with available stored tissue blocks or slides
- willing to donate 16cc of blood
- able to understand English and provide informed consent
Exclusion
- unable or unwilling to provide informed consent
- patient does not have tissue blocks available
- minor, under age 18
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 14 2022
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01167842
Start Date
October 1 2009
End Date
January 14 2022
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195